UPDATE : Friday, October 18, 2019
상단여백
Hanmi spurs new immunotherapy development through open innovation by Lee Han-soo 2019-09-17 18:14
Government allows new drugs to treat multidrug-resistant TB by Kim Eun-young 2019-09-17 16:28
Regulator finds no trace of carcinogen in GSK’s heartburn drug by Lee Han-soo 2019-09-17 16:27
‘Lundbeck to work with parliament to prevent suicide in Korea’ by Kim Yun-mi 2019-09-17 15:19
Shinpoong's malaria treatment expands global presence by Lee Han-soo 2019-09-17 15:13
라인
Noom, NCC to jointly research total healthcare for cancer patients by Lee Han-soo 2019-09-17 11:28
SK Bioscience to export influenza vaccine to Asian countries by Lee Han-soo 2019-09-17 11:27
Biotech startups seek IPO via ‘growth potential exception’ policy by Jeong Sae-im 2019-09-17 11:26
Gyeongsang National University develops early dementia detection kit by Lee Han-soo 2019-09-16 18:05
Myongji Hospital to hold international liver symposium by Lee Han-soo 2019-09-16 17:42
라인
Lenvima to get benefit as 1st-line treatment of hepatocellular carcinoma by Kim Yun-mi 2019-09-16 16:20
'Roche Korea to put patient accessibility first' by Lee Han-soo 2019-09-16 15:41
Regulator inspects heartburn drugs after US finds carcinogen by Lee Hye-seon 2019-09-16 14:01
GC’s Hunter syndrome drug to get priority screening in China by Lee Han-soo 2019-09-16 13:56
FDA warns against pneumonitis with CDK 4/6 inhibitor drugs for breast cancer by Kim Yun-mi 2019-09-16 11:39
라인
Number of antibiotic-resistant infections increase faster than 2018 by Lee Han-soo 2019-09-12 07:23
GSK’s chronic hand eczema treatment faces local competition by Lee Han-soo 2019-09-12 07:22
KCDC pegs salted clam as culprit behind hepatitis A rise by Lee Han-soo 2019-09-12 07:22
Korea sees a spike in depression, bipolar disorder by Lee Han-soo 2019-09-11 15:16
Chong Kun Dang wins patent suit against Novartis over immunosuppressant by Jeong Sae-im 2019-09-11 15:16
여백
여백
여백
Back to Top